A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants

PHASE2CompletedINTERVENTIONAL
Enrollment

284

Participants

Timeline

Start Date

October 11, 2019

Primary Completion Date

June 22, 2021

Study Completion Date

June 22, 2021

Conditions
HypothyroidismThyroid DiseaseEuthyroidThyroid GlandThyroid Hormones
Interventions
DRUG

Armour® Thyroid

Administered orally once a day. the daily dose could range from 1/4 - 2 grains.

DRUG

Levothyroxine

Administered orally once a day; the daily dose could range from 25- 200 µg.

Trial Locations (28)

27834

Sponsor Site/ID# 235204, Greenville

28601

Sponsor Site /ID# 238023, Hickory

28803

Sponsor Site /ID# 235202, Asheville

30046

Sponsor Site /ID# 238088, Lawrenceville

30318

Sponsor Site /ID# 235032, Atlanta

31904

Sponsor Site /ID# 237199, Columbus

33312

Sponsor Site /ID# 235853, Fort Lauderdale

33401

Sponsor Site /ID# 236809, West Palm Beach

35205

Sponsor Site /ID# 237950, Birmingham

40503

Sponsor Site /ID# 235714, Lexington

75231

Sponsor Site/ID# 237652, Dallas

Sponsor Site/ID# 237655, Dallas

78229

Sponsor Site /ID# 235894, San Antonio

78681

Sponsor Site /ID# 235860, Round Rock

78731

Sponsor Site /ID# 237137, Austin

78749

Sponsor Site/ID# 238071, Austin

79935

Sponsor Site /ID# 235870, El Paso

80246

Sponsor Site/ID# 235866, Denver

91321

Sponsor Site /ID# 238026, Santa Clarita

92648

Sponsor Site /ID# 235716, Huntington Beach

94904

Sponsor Site /ID# 235210, Greenbrae

98057

Sponsor Site /ID# 235211, Renton

98405

Sponsor Site/ID# 236977, Tacoma

99202

Sponsor Site /ID# 236022, Spokane

72209-7040

Sponsor Site /ID# 237986, Little Rock

95821-2123

Sponsor Site /ID# 238120, Sacramento

91405-3605

Sponsor Site /ID# 238258, Van Nuys

40213-1014

Sponsor Site /ID# 236701, Louisville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY